Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi SA
Euronext: ROVI.MC
Headquarters
Spain 
Number of employees
1,419 (2024) 
Websitewww.rovi.es/en

Laboratorios Farmaceuticos Rovi SA (Euronext: ROVI.MC) is a Spanish pharmaceutical company.[1]

The company is a member of the IBEX 35 stock market index.[2]

History

Laboratorios Farmaceuticos Rovi was founded in 1946.[3]

Finances

In 2024, the company's revenue was €763.7 million, a 7.9% decrease from 2023. Net profit was €136.9 million.[4]

References

  1. ^ "Spanish drugmaker Rovi to keep third-party manufacturing business". Reuters. 24 October 2024. Retrieved 5 November 2025.
  2. ^ "Rovi entra este lunes en el Ibex 35 en sustitución de Viscofan" [Rovi enters the Ibex 35 this Monday to replace Viscofan]. Europa Press (in Spanish). Madrid. 20 December 2021. Archived from the original on 17 January 2025. Retrieved 5 November 2025.
  3. ^ "History". Laboratorios Farmaceuticos Rovi. Retrieved 5 November 2025.
  4. ^ "Rovi Achieved Revenue of 764.6 Million Euros and Increased Its Gross Margin by 3.7 Percentage Points" (Press release). Laboratorios Farmaceuticos Rovi. 25 February 2025. Retrieved 5 November 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.